Empire Financial Management Company’s GSK GSK Stock Holding History

Empire Financial Management Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,212	Closed	-$453K	–	174
2026 Q1	$453K	Sell	8,212 -5,754	-41%	-$312K	0.1%	162
2025 Q4	$685K	Hold	13,966	–	–	0.15%	133
2025 Q3	$603K	Hold	13,966	–	–	0.14%	140
2025 Q2	$536K	Hold	13,966	–	–	0.15%	141
2025 Q1	$541K	Sell	13,966 -7,500	-35%	-$275K	0.17%	135
2024 Q4	$726K	Buy	21,466 +5,754	+37%	+$207K	0.23%	118
2024 Q3	$642K	Sell	15,712 -8,000	-34%	-$327K	0.2%	128
2024 Q2	$913K	Sell	23,712 -22,500	-49%	-$946K	0.3%	98
2024 Q1	$1.98M	Buy	46,212 +19,885	+76%	+$820K	0.65%	49
2023 Q4	$976K	Sell	26,327 -125	-0.5%	-$4.49K	0.38%	73
2023 Q3	$959K	Buy	26,452 +10,000	+61%	+$355K	0.42%	71
2023 Q2	$586K	Hold	16,452	–	–	0.23%	106
2023 Q1	$585K	Buy	+16,452	New	+$576K	0.24%	103

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Empire Financial Management Company's GSK Position: Q2 2026 in Review

Empire Financial Management Company sold out of GSK (GSK) in Q2 2026, closing a stake of 8,212 shares — an estimated $453K sold.

Empire Financial Management Company first reported a position in GSK in Q1 2023 and held it in 13 quarters. The position peaked at $1.98M in Q1 2024. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Empire Financial Management Company reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
Empire Financial Management Company sold 8,212 GSK shares in Q2 2026, an estimated $453K.
Empire Financial Management Company first reported a position in GSK in Q1 2023 and held it in 13 quarters.
Empire Financial Management Company's GSK position peaked at $1.98M in Q1 2024.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Empire Financial Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.